These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11987687)

  • 1. [Anti-CD25 monoclonal antibody against polyclonal antibodies in pediatric renal transplantation].
    Zamora I; Berbel O; Simón J; Sanahuja MJ
    Nefrologia; 2002; 22(1):66-70. PubMed ID: 11987687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function.
    González E; Gutiérrez E; Hernández Y; Roselló G; Gutiérrez MJ; Martínez EG; Manzanera MJ; García JA; Praga M; Morales JM; Andrés A
    Transplant Proc; 2005 Nov; 37(9):3736-7. PubMed ID: 16386522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of anti-IL-2 receptor in high-risk kidney transplant patients.
    Jirasiritham S; Sumethkul V; Mavichak V; Lertsithichai P; Jirasiritham S
    Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
    N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
    Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients.
    Grego K; Arnol M; Bren AF; Kmetec A; Tomaziĉ J; Kandus A
    Transplant Proc; 2007 Dec; 39(10):3093-7. PubMed ID: 18089329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial data on basiliximab in critically ill children undergoing heart transplantation.
    Ford KA; Cale CM; Rees PG; Elliott MJ; Burch M
    J Heart Lung Transplant; 2005 Sep; 24(9):1284-8. PubMed ID: 16143246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W
    Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation.
    Di Filippo S
    Pediatr Transplant; 2005 Jun; 9(3):373-80. PubMed ID: 15910396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation.
    Taber DJ; Weimert NA; Henderson F; Lin A; Bratton CF; Chavin KD; Baliga PK
    Transplant Proc; 2008 Dec; 40(10):3401-7. PubMed ID: 19100399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients.
    Ganschow R; Grabhorn E; Schulz A; Von Hugo A; Rogiers X; Burdelski M
    Pediatr Transplant; 2005 Dec; 9(6):741-5. PubMed ID: 16269045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study.
    Gibelli NE; Pinho-Apezzato ML; Miyatani HT; Maksoud-Filho JG; Silva MM; Ayoub AA; Santos MM; Velhote MC; Tannuri U; Maksoud JG
    Transplant Proc; 2004 May; 36(4):956-7. PubMed ID: 15194332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
    Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
    Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation.
    Al Najjar A; Etienne I; Le Pogamp P; Bridoux F; Le Meur Y; Toupance O; Mousson C; Caillard S; Hurault de Ligny B; Marlière JF; Lebranchu Y
    Transplant Proc; 2006 Sep; 38(7):2298-9. PubMed ID: 16980070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basiliximab and heart transplantation in Hispanics: the experience in Puerto Rico.
    Banchs HL; Carro Jiménez EJ; González V; González Cancel IF; Quintana C; Calderón R; Altieri PI; Rivera C
    Bol Asoc Med P R; 2007; 99(3):191-6. PubMed ID: 19610574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological evaluation of renal allograft treated with anti-CD25 monoclonal antibody.
    Okamoto M; Akioka K; Higuchi A; Kadotani Y; Ushigome H; Uryuhara K; Kaihara S; Yoshimura N
    Clin Transplant; 2005; 19 Suppl 14():49-53. PubMed ID: 15955169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
    Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
    Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.
    Adu D; Cockwell P; Ives NJ; Shaw J; Wheatley K
    BMJ; 2003 Apr; 326(7393):789. PubMed ID: 12689974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation.
    Orr DW; Portmann BC; Knisely AS; Stoll S; Rela M; Muiesan P; Bowles MJ; Heaton ND; O'Grady JG; Heneghan MA
    Transplant Proc; 2005 Dec; 37(10):4373-9. PubMed ID: 16387124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.